| Literature DB >> 26039538 |
Sharon Sanders1, Jenny Doust1, Paul Glasziou1.
Abstract
BACKGROUND: Diagnostic clinical prediction rules (CPRs) are developed to improve diagnosis or decrease diagnostic testing. Whether, and in what situations diagnostic CPRs improve upon clinical judgment is unclear. METHODS ANDEntities:
Mesh:
Year: 2015 PMID: 26039538 PMCID: PMC4454557 DOI: 10.1371/journal.pone.0128233
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1PRISMA flow diagram of article selection process.
Clinical conditions and study comparisons.
| Clinical condition | Number of studies (number of comparisons) | Methods of estimating a probability, making a diagnosis or management decision being compared (number of comparisons) |
|---|---|---|
| Pulmonary embolism [ | 9 | CPR versus clinical judgment alone (1) |
| CPR versus clinical judgment + structured data collection (13) | ||
| CPR versus combination of clinical judgment and CPR (2) | ||
| Deep vein thrombosis [ | 6 (7) | CPR versus clinical judgment alone (1) |
| CPR versus clinical judgment + structured data collection (5) | ||
| CPR versus combination of clinical judgment and CPR (1) | ||
| Streptococcal throat infection [ | 3 (5) | CPR versus clinical judgment + structured data collection (5) |
| Ankle or foot fracture [ | 3 (4) | CPR versus clinical judgment alone (1) |
| CPR versus clinical judgment + structured data collection (3) | ||
| Acute appendicitis [ | 2 (2) | CPR versus clinical judgment alone (1) |
| CPR versus combination of clinical judgment and CPR (1) | ||
| Acute coronary syndrome [ | 1 (1) | CPR versus clinical judgment + structured data collection (1) |
| Pneumonia [ | 1 (4) | CPR versus clinical judgment + structured data collection (4) |
| Abnormalities on computed tomography scan in child with head injury [ | 1 (1) | CPR versus clinical judgment alone (1) |
| Cervical spine injuries [ | 1 (1) | CPR versus combination of clinical judgment and CPR (1) |
| Active pulmonary tuberculosis [ | 1 (1) | CPR versus clinical judgment + structured data collection (1) |
| Malaria [ | 1 (2) | CPR versus clinical judgment alone (2) |
| Bacteremia [ | 1 (1) | CPR versus clinical judgment + structured data collection (1) |
| Influenza [ | 1 (1) | CPR versus clinical judgment alone (1) |
* 8 cohorts
Fig 2Summary QUADAS-2 [7] risk of bias and applicability judgments.
Risk of bias and applicability concerns for individual studies included in the review.
| Study | Risk of Bias | Concerns regarding Applicability | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Patient selection | Index test (CPR) | Index test (clinical judgment) | Reference standard | Flow and timing | Patient selection | Index test (CPR) | Index test (clinical judgment) | Reference standard | |
| Pulmonary embolism | |||||||||
| Runyon et al, 2005 [ | Unclear | Unclear | Low | Low | High | Low | Low | Low | Low |
| Kabrhel et al, 2009 [ | Low | Unclear | Low | Unclear | High | Unclear | Low | Low | Low |
| Kline et al, 2008 [ | Low | Unclear | Low | Unclear | Unclear | Unclear | Low | Low | Low |
| Kabrhel et al, 2005[ | Unclear | Unclear | Low | Unclear | High | Unclear | Low | Low | Low |
| Carrier et al, 2006 [ | Low | Unclear | Low | Unclear | High | Low | Low | Low | Low |
| Chagnon et al, 2002 [ | Low | Unclear | Low | Unclear | High | Unclear | Low | Low | Low |
| Penaloza et al, 2012 [ | Low | Unclear | Low | Unclear | High | Low | Low | Low | Low |
| Sanson et al, 2000 [ | Low | Unclear | Low | Unclear | High | Low | Low | Low | Low |
| Penaloza et al, 2013 [ | Low | Unclear | Low | Unclear | High | Low | Low | Low | Low |
| Deep vein thrombosis | |||||||||
| Geersing et al, 2010 [ | Low | Low | Low | Unclear | High | Low | Low | Low | Low |
| Bigaroni et al,2000[ | Low | Low | Low | Unclear | Unclear | Low | Low | Low | Low |
| Miron et al, 2000 [ | Low | Low | Low | High | High | Low | Low | Low | Low |
| Blattler et al, 2004 [ | Low | High | Low | Unclear | Low | Low | Low | Low | Low |
| Cornuz et al, 2002 [ | Low | Low | Low | Low | High | Low | Low | Low | Low |
| Wang et al, 2013 [ | Unclear | Unclear | Low | Unclear | Unclear | Low | Low | Low | Low |
| Streptococcal throat infection | |||||||||
| Cebul and Poses, 1986 [ | Unclear | Unclear | Low | Low | High | Low | Low | Low | Low |
| Rosenberg et al, 2002 [ | High | Unclear | Low | Low | High | Low | Low | Low | Low |
| Attia et al, 2001 [ | Unclear | Unclear | Low | Low | High | Unclear | Low | Low | Low |
| Ankle or foot fracture | |||||||||
| Glas et al, 2002 [ | Low | Unclear | Low | Low | Low | Low | Low | Low | Low |
| Singh-Ranger and Marathias, 1999 [ | Low | Low | Low | Unclear | Low | Low | Low | Low | Low |
| Al Omar and Baldwin, 2002 [ | Unclear | Low | Low | Unclear | Low | Low | Low | Low | Low |
| Conditions with ≤ 2 studies | |||||||||
| Fenyo, 1987 [ | Low | Low | Low | Unclear | High | Low | Low | Low | Low |
| Meltzer et al, 2013 [ | Unclear | Unclear | Low | Unclear | High | Low | Low | Low | Low |
| Mitchell et al, 2006 [ | Low | Unclear | Low | Unclear | Unclear | Low | Low | Low | Low |
| Emerman et al, 1991 [ | Unclear | Unclear | Low | Low | Low | Low | Low | Low | Low |
| Crowe et al, 2010 [ | High | Unclear | Low | Unclear | Unclear | Low | Unclear | Low | Low |
| Vaillancourt et al, 2009 [ | High | Unclear | Low | Low | High | Low | Low | Low | Low |
| El-Solh et al, 1999 [ | Low | Unclear | Low | Low | Low | Low | Low | Low | Unclear |
| Bojang et al, 2000 [ | Unclear | Low | Low | Low | Low | Low | Low | Low | Low |
| Leibovici et al, 1991 [ | Low | Unclear | Unclear | Low | Low | Low | Low | Low | Low |
| Stein et al, 2005[ | Unclear | Unclear | Low | Low | Unclear | Low | Low | Low | Low |
* In studies where the CPR is applied retrospectively to the data by the researcher using predictor data collected by the clinician, if there was no statement that researchers were blind to the reference standard the risk of bias was considered to be unclear. If predictor data was collected by the researcher and there was no statement that researchers were blind to the reference standard, the risk of bias was considered to be high.
†When the reference standard comprised subjective tests, if there was no statement that those interpreting the reference standard tests were blind to the results of either the CPR or clinician, the risk of bias was considered to be unclear.
‡If the method of determining disease status involved a combination of different tests in which some tests were applied to some patients and one test applied to all patients (differential verification) then the risk of bias was considered to be unclear. If performance of any of the reference standard tests was dependent upon the results of the index test, the risk of bias was considered to be high. If it was not possible to determine whether all eligible patients had been included in the analysis the risk of bias was considered to be unclear. If it was clear that not all patients had been included in the analysis (due to missing outcome data or because data from the clinicians estimate or data necessary to derive the results of the CPR were not available) and these studies reported results for the comparisons in different numbers of cases or only presented the results for cases on which data for both the comparisons was available, the risk of bias was considered to be high. Risk of bias was recorded as high if either of the issues relating to the reference standard test or analysis were high.
Characteristics and results of included studies.
| Study | Setting | Method of establishing status of target disorder | Prevalence (n/N) | Comparison (method of estimating the probability of target disorder, making a diagnosis or management decision) | Threshold (low risk if) | Sensitivity (95% CI) | Specificity (95% CI) | % missed cases of disease among those classified as not having disease (95% CI) | % classified as not having disease (95% CI)+ |
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Runyon et al, 2005 [ | ED | Medical record review, F/U by mail or telephone and death records at 1.5 months | 6% (144/2477) |
| <15% | 69 (61–76) | 72 (70–74) | 2.6 (1.9–3.5) | 69 (67–71) |
|
| <2 | 62 (54–70) | 75 (73–77) | 3.0 (2.3–3.9) | 73 (70–74) | ||||
|
| Safe | 36 (28–45) | 89 (88–91) | 4.2 (3.5–5.2) | 88 (87–89) | ||||
| Kabrhel et al, 2009 [ | ED | Adjudicated review of imaging results, medical records and F/U at 1.5 months | 7% (545/7940) |
| <15% | 69 (65–73) | 70 (69–71) | 3.1 (2.7–3.6) | 68 (67–69) |
|
| <2 | 68 (64–72) | 72 (71–73) | 3.2 (2.7–3.7) | 69 (68–70) | ||||
| Kline et al, 2008 [ | ED | Adjudicated review of imaging results, medical records and F/U at 1.5 months | 7% (561/8138) |
| <15% | 71 (67–74) | 69 (68–71) | 3.0 (2.6–3.5) | 67 (66–68) |
|
| No criteria present | 96 (94–97) | 25 (24–26) | 1.3 (0.9–1.9) | 24 (23–25) | ||||
| Kabrhel et al, 2005 [ | ED | Review of medical records at 3 months F/U | 10% (61/607) |
| Alternate diagnosis not less likely | 54 (41–67) | 76 (73–80) | 6.3 (4.4–8.9) | 73 (70–77) |
|
| <2 | 79 (66–88) | 57 (53–61) | 4.0 (2.4–6.7) | 54 (50–58) | ||||
| ≤4 | 59 (46–72) | 78 (74–81) | 5.5 (3.8–8.1) | 74 (70–77) | |||||
| Carrier et al, 2006 [ | NMD | Patient follow-up by telephone or return appointment at 3 months | 18% (76/413) |
| <20% | 86 (76–93) | 38 (33–43) | 7.5 (4.3–13.0) | 34 (30–38) |
|
| ≤2 | 95 (87–99) | 19 (15–24) | 5.8 (2.3–14.0) | 17 (13–21) | ||||
| ≤4 | 83 (73–91) | 41 (35–46) | 8.7 (5.1–14.3) | 36 (32–41) | |||||
|
| No criteria present | 96 (89–99) | 9 (6–13) | 3.2 (1.1–8.9) | 24 (20–28) | ||||
| Chagnon et al, 2002 [ | ED | Follow-up (method not specified) at 3 months | 26% (71/277) |
| ‘low’ | 89 (79–95) | 67 (60–73) | 5.5 (2.8–10.4) | 53 (47–59) |
|
| <2 | 73 (61–83) | 69 (63–76) | 11.7 (7.6–17.6) | 59 (53–64) | ||||
|
| ≤4 | 72 (60–82) | 64 (57–71) | 13.2 (8.7–19.5) | 55 (49–61) | ||||
| Penaloza et al, 2012 [ | ED | Review of imaging results, medical records and patient or relative follow-up at 3 months | 30% (286/959) |
| ‘low’ | 91 (87–94) | 55 (52–59) | 6.5 (4.5–9.4) | 42 (39–45) |
|
| <4 and no criteria present | 99 (97–99.6) | 9 (7–12) | 6.2 (2.4–14.8) | 7 (5–9) | ||||
|
| No criteria present | 99 (97–99.6) | 10 (8–13) | 5.4 (2.1–13.1) | 8 (6–10) | ||||
| Sanson et al, 2000 [ | IP, OPD | Perfusion lung scintigraphy or pulmonary angiography | 31% (160/517) |
| <20% | 91 (85–96) | 16 (12–21) | 19.0 (10.9–30.9) | 14 (11–18) |
|
| <2 | 66 (57–75) | 36 (31–42) | 27.9 (21.3–35.6) | 36 (31–40) | ||||
| Penaloza et al, 2013 [ | ED | Review of imaging results, medical records and patient or relative follow-up at 3 months | 31% (325/1038) |
| ‘low’ | 90 (86–93) | 58 (54–61) | 7.6 (5.5–10.5) | 43 (40–46) |
|
| <2 | 82 (77–85) | 60 (56–63) | 12.6 (9.9–15.8) | 47 (44–50) | ||||
|
| <4 | 89 (85–92) | 33 (30–37) | 13.0 (9.5–17.5) | 26 (23–29) | ||||
|
| |||||||||
|
|
|
|
|
|
|
|
|
|
|
| Geersing et al, 2010 [ | PC | Clinical probability, ultrasound and F/U at 3 months | 14% 136/1002 |
| <10% | 98 (94–99) | 24 (22–27) | 1.4 (0.5–4.0) | 21 (19–24) |
|
| < = 3 | 95 (90–98) | 57 (54–60) | 1.4 (0.6–2.9) | 50 (47–53) | ||||
| Bigaroni et al, 2000 [ | ED, OPD | D-dimer, ultrasound, other imaging and telephone F/U at 3 months | 17% (28/165) |
| ‘Low risk’ | 98 (85–99.8) | 46 (38–54) | 0.0 (0.0–5.8) | 38 (31–46) |
|
| <1 | 71 (53–85) | 75 (67–82) | 7.2 (3.7–13.6) | 67 (60–74) | ||||
|
| <1 | 79 (61–90) | 74 (66–80) | 5.6 (2.6–11.7) | 65 (57–72) | ||||
| Miron et al, 2000 [ | ED, OPD | D-dimer, ultrasound, other imaging and telephone F/U at 3 months | 21%(57/270) |
| <20% | 98 (91–99.7) | 36 (30–43) | 1.3 (0.2–6.9) | 29 (24–35) |
|
| <1 | 93 (83–97) | 57 (50–63) | 3.2 (1.3–7.9) | 46 (40–52) | ||||
| Blattler et al, 2004 [ | OPD | Ultrasound and telephone F/U at 6+ months | 28%(57/206) |
| ‘Low risk’ | 81(69–89) | 85 (79–90) | 8.0 (4.5–13.7) | 67 (60–73) |
|
| Low | 54 (42–67) | 84 (77–89) | 17.2 (12.0–24.0) | 73 (67–79) | ||||
| Cornuz et al, 2002 [ | VL | Ultrasound, other imaging, mail or telephone F/U | 29% (82/278) |
| <20% | 87 (78–92) | 38 (32–45) | 12.8 (7.3–21.5) | 31 (26–37) |
|
| <1 | 83 (73–90) | 49 (42–56) | 12.8 (7.8–20.4) | 39 (34–45) | ||||
| Wang et al, 2013 [ | OPD | Ultrasound and telephone or email F/U at 1.5 months | 47% (191/405) |
| ‘Safe’ | 76 (70–82) | 89 (84–92) | 19.2 (14.6–24.7) | 58 (53–63) |
|
| < = 1 | 62 (55–69) | 72 (66–78) | 31.9 (26.1–38.2) | 56 (51–61) | ||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||
| Cebul and Poses, 1986 [ | PC/ Adults | Throat culture | 5% (15/310) |
| No treatment | 53 (27–79) | 68 (62–73) | 3.4 (1.7–6.9) | 67 (61–72) |
|
| No treatment | 80 (52–95) | 67 (61–72) | 1.5 (0.5–4.3) | 65 (59–70) | ||||
|
| No treatment | 100 (75–100) | 66 (60–72) | 0.0 (0.0–2.2) | 63 (57–69) | ||||
| Rosenberg et al, 2002 [ | ED/ Mixed | Pharyngeal swab culture | 25% (32/126) |
| No treatment | 90 (74–98) | 92 (87–95) | 5.0 (2.0–12.2) | 64 (55–71) |
|
| No treatment | 97 (84–99.5) | 78 (68–86) | 1.4 (0.2–7.3) | 59 (50–67) | ||||
| Attia et al, 2001 [ | ED, OPD/Children | Tonsillopharyngeal swab culture | 37% (218/587) |
| < = 50% | 72 (66–78) | 60 (55–65) | 21.6 (17.2–26.7) | 48 (44–52) |
|
| 0 | 99 (97–99.9) | 5 (3–7) | 11.8 (3.3–34.3) | 3 (2–5) | ||||
| < = 3 | 18 (13–24) | 97 (95–99) | 34.7 (30.7–39.0) | 91 (89–94) | |||||
|
| |||||||||
|
|
|
|
|
|
|
|
|
|
|
| Glas et al, 2002 [ | ED/ Adults | Ankle and midfoot x-ray | 6% (41/647) |
| No X-ray | 98 (87–99.6) | 66 (62–70) | 0.3 (0.0–1.4) | 62 (59–66) |
|
| Negative | 98 (87–99.6) | 26 (22–29) | 0.6 (0.1–3.5) | 24 (21–28) | ||||
|
| < = 7 | 88 (74–96) | 57 (53–61) | 1.4 (0.6–3.3) | 55 (51–58) | ||||
| Singh-Ranger and Marathias 1999 [ | ED/ Adults | Ankle x-ray | 17% (3/18) |
| No fracture | 100 (31–100) | 0.0 (0.0–22) | 0.0 (0.0–0.0) | 0 (0–18) |
|
| Negative | 100 (31–100) | 67 (38–85) | 0.0 (0.0–27.8) | 56 (34–75) | ||||
| Al Omar and Baldwin 2002 [ | ED/ Children | Ankle or midfoot x-ray | 21% (17/80) |
| No fracture | 65 (38–86) | 76 (64–86) | 11.1 (5.2–22.2) | 68 (57–77) |
|
| Negative | 100 (80–100) | 30 (19–43) | 0.0 (0.0–16.8) | 24 (16–34) |
*% missed cases of disease among those classified as not having disease (FN/FN+TN or 1-negative predictive value)
†% classified as not having disease (FN+TN/total study N)
§ankle or midfoot fracture
ǁ ankle fracture Includes Salter Harris fractures
**2-category Wells DVT score
ED – emergency department OPD – Outpatient department VL – vascular laboratory PC – primary care NMD – nuclear medicine department F/U – follow-up OAR – Ottawa ankle rules PE – pulmonary embolism DVT- deep vein thrombosis
Characteristics and results of included studies for conditions with ≤2 studies.
| Study | Setting | Method of establishing disease status | Prevalence (n/N) | Comparison (method of estimating probability, making diagnosis or management decision) | Threshold (low risk if) | Sensitivity (95%CI) | Specificity (95% CI) | % missed cases of disease among those classified as not having disease (95% CI) | % classified as not having disease (95% CI) |
|---|---|---|---|---|---|---|---|---|---|
| Fenyo, 1987 [ | IP | Intraop diagnosis, histopathology of excised appendices and record review at 1–2 years | 31% (256/830) |
| No surgery | 100 (99–100) | 91 (88–93) | 0.0 (0.0–0.7) | 63 (59–66) |
|
| ≤11 | 90 (86–94) | 92 (89–94) | 4.6 (3.1–6.6) | 66 (63–69) | ||||
| Meltzer et al, 2013 [ | ED | Surgical pathology, CT scan or telephone F/U at 7 days | 20% (53/261) |
| Appendicitis not most likely diagnosis | 79 (66–89) | 68 (61–74) | 7.2 (4.1–12.5) | 58 (52–64) |
|
| <4 | 72 (58–83) | 54 (47–61) | 11.8 (7.3–18.6) | 49 (43–55) | ||||
| Mitchell et al, 2006[(31] | ED | Review of medical records and telephone F/U at 1.5 months | 5% (51/1114) |
| ≤2% | 96 (87–99) | 27 (25–30) | 0.7 (0.2–2.5) | 26 (24–29) |
|
| ≤2% | 100 (93–100) | 5 (4–7) | 0.0 (0.0–6.4) | 5 (4–7) | ||||
| Emerman et al, 1991 [ | ED, OPC | Posteroanterior and lateral chest x-ray | 7% (21/290) |
| No radiograph | 86 (64–97) | 58 (52–64) | 1.9 (0.7–5.4) | 55 (49–60) |
|
| ≤0 | 67 (43–85) | 67 (61–73) | 3.7 (1.8–7.5) | 65 (59–70) | ||||
|
| <2 | 71 (48–89) | 67 (61–73) | 3.3 (1.5–6.8) | 65 (59–70) | ||||
|
| No variable present | 62 (39–82) | 76 (70–81) | 3.8 (1.9–7.2) | 74 (68–78) | ||||
|
| Probability <0.26 | 76 (53–92) | 55 (49–61) | 3.3 (1.4–7.4) | 53 (47–58) | ||||
| Crowe et al, 2010 [ | ED | Medical record review of imaging tests, observation and readmission | 7% (73/1065) |
| No CT scan | 95 (87–98) | 86 (84–88) | 0.5 (0.2–1.2) | 81 (78–83) |
|
| No criteria present | 89 (80–95) | 57 (54–60) | 1.4 (0.7–2.7) | 54 (51–57) | ||||
| Vaillancourt et al, 2009 [ | ES | Radiographic imaging and telephone or mail F/U at 14 days | 1% (12/1974) |
| Negative | 100 (73–100) | 38 (36–40) | 0.0 (0.0–0.5) | 38 (35–40) |
|
| Negative | 100 (73–100) | 43 (40–45) | 0.0 (0.0–0.6) | 43 (40–45) | ||||
| El Solh et al, 1999 [ | IP | Culture of respiratory specimens | 9% (11/119) |
| No active TB | 64 (31–89) | 79 (70–86) | 4.5 (1.8–11.0) | 75 (66–82) |
|
| Negative | 100 (71–100) | 69 (60–78) | 0.0 (0.0–4.9) | 63 (54–71) | ||||
| Bojang et al, 2000 [ | OPD | Temperature and parasitemia on blood film | 35% (133/382) |
| No malaria | 82 (74–88) | 61 (55–67) | 13.6 (9.3–19.5) | 46 (41–51) |
|
| <7 | 90 (83–94) | 63 (57–69) | 8.2 (4.9–13.3) | 46 (41–51) | ||||
| <8 | 90 (83–95) | 78 (72–83) | 17.1 (12.8–22.4) | 61 (56–66) | |||||
| Leibovici et al, 1991[ | IP | Blood culture | 14% (36/257) |
| No bacteremia | 53 (36–70) | 84 (79–89) | 8.5 (5.4–13.2) | 79 (74–84) |
|
| <20% | 97 (85–99.5) | 60 (53–67) | 0.8 (0.1–4.2) | 52 (46–58) | ||||
| Stein et al, 2005 [ | ED | Reverse transcriptase PCR assay for influenza A and B | 21% (53/258) |
| No influenza | 29 (17–44) | 92 (87–95) | 18.0 (13.2–24.1) | 87 (82–91) |
|
| Negative | 41 (27–57) | 92 (87–95) | 14.8 (10.4–20.7) | 84 (78–88) |
*% missed cases of disease (FN/FN+TN or 1-NPV)
†% classified as low risk (FN+TN/total N)
Fig 3Results of the included studies.
Fig 4Results of the included studies for conditions with ≤ 2 studies.